Access cutting-edge cancer treatment through this clinical trial at a research site in Rockville. Study-provided care at no cost to qualified participants.
Access cancer specialists in Rockville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with locally advanced or metastatic solid tumors, or recurrent or progressive primary central nervous system (CNS) tumors harboring BRAF fusions, or in participants with rare BRAF V600-mutated solid tumors, melanoma, thyroid, or recurrent primary CNS tumors.
Sponsor: Fore Biotherapeutics
Check if you qualify for this cancer clinical trial in Rockville, MD
If you're searching for cancer treatment options in Rockville, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rockville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.